FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories Potassium Chloride Extended-Release Tablets Recall

Potassium Chloride Extended-Release Tablets, USP, 10 mEq (750 mg), 100 Tablets per cart…

The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories · La Vergne, TN

Risk level
Class II
Reported by FDA
Feb 12, 2025
Recall ID
D-0221-2025
Check your lot numberHow we source this data

Summary

The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories recalled Potassium Chloride Extended-Release Tablets starting Jan 30, 2025. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0221-2025 on Feb 12, 2025. Reason: Failed Dissolution Specifications. Status: Ongoing.

Why it was recalled

Failed Dissolution Specifications.

Product description

Potassium Chloride Extended-Release Tablets, USP, 10 mEq (750 mg), 100 Tablets per carton (10 x 10 unit dose blisters), Rx Only, Distributed by: Aurobindo Pharma USA< INC., 279 Princeton-Hightstown Road, East Windsor, NJ 08520. Made in India. Distributed by: MAJOR PHARMACEUTICALS, Livonia, MI 48152. NDC: 0904-7216-61

Lot numbers, UPCs & expiration codes

Lot# T05224; Exp. 02/2026

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0221-2025
Classification
Class II
Status
Ongoing
Recall initiated
Jan 30, 2025
FDA report date
Feb 12, 2025
Quantity
6997 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories

Original FDA data

Every field from FDA enforcement report D-0221-2025, exactly as published.

Show all FDA fields
City
La Vergne
State
TN
Status
Ongoing
Country
United States
Event ID
96201
Address
341 Mason Rd
Code information
Lot# T05224; Exp. 02/2026
Postal code
37086-3606
Report date
Feb 12, 2025
Product type
Drugs
Recall number
D-0221-2025
Classification
Class II
Recalling firm
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories
Product quantity
6997 cartons
Reason for recall
Failed Dissolution Specifications.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Potassium Chloride Extended-Release Tablets, USP, 10 mEq (750 mg), 100 Tablets per carton (10 x 10 unit dose blisters), Rx Only, Distributed by: Aurobindo Pharma USA< INC., 279 Princeton-Hightstown Road, East Windsor, NJ 08520. Made in India. Distributed by: MAJOR PHARMACEUTICALS, Livonia, MI 48152. NDC: 0904-7216-61
Distribution pattern
Nationwide in the USA
Recall initiation date
Jan 30, 2025
Initial firm notification
Letter
Center classification date
Feb 4, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0221-2025, published Feb 12, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls